Loading...

GUFICBIO Gufic BioSciences Ltd Significant changes in accounting policies or practices Announcement

Gfc

GFCB

Gufic BioSciences Ltd

(GUFICBIO)

2024 Announcement

ESG rating disclosure

Special Window for Transfer...

Earnings Call Transcript

Analyst / Institutional mee...

Earnings Conference Call

Newspaper advertisement

Investor Presentation

Unaudited Results

Unaudited Financial Results...

Earnings Conference Call

Credit Rating Update

Board Meeting Notice

Investor Education Campaign

Compliance Certificate

Share Transfer Update

Investor Meeting

Management Promotion

41st AGM Notice

Annual General Meeting

Gufic Acquisition Update

Earnings Call Transcript

Earnings Call Audio

Financial Results Published

Investor Presentation

Statutory Auditor Appointment

Management Change

Earnings Call Announcement

Transfer Requests Window

Equity Allotment Update

Compliance Certificate

Share Transfer Notice

Management Appointment

Management Resignation

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Investor Presentation

Acquisition Update

Subsidiary Investments

Management Changes

Annual Compliance Report

Earnings Call Notice

Cost Auditor Resignation

RTA Contact Update

Tax Appeal Filed

Compliance Certificate

Tax Demand Notice

Earnings Call Transcript

Investor Meeting

Earnings Call Recording

Financial Results Published

Investor Presentation

Earnings Call Scheduled

Investor Meeting

Management Appointments

Management Appointment

Equity Share Acquisition

Postal Ballot Notice

Regulation Compliance

RTA Name Change

Earnings Call Transcript

Director Change

Regulatory Fine Imposed

Earnings Call Update

Financial Results

Investor Presentation

Director Appointment

Investor Meeting

Earnings Call Announcement

Compliance Certificate

Directorate Change

Annual General Meeting

Annual General Meeting

Regulatory Fine Dispute

Earnings Call Transcript

Financial Results Update

Earnings Call Recording

Investor Presentation

Directorate Changes

Director Resignation

Earnings Conference Call

Analyst Meeting

Credit Rating Upgrade

Certificate Submission

Equity Shares Transfer to I...

Director Change

Grant of Options

Directorate Change

Director Resignation

Meeting Intimation

Volume Increase Clarification

Earnings Call Transcript

Retirement Announcement

Financial Results Advertise...

Investor Presentation

Earnings Conference Call

Secretarial Compliance

Certificate Submission

Compliance Certificate Subm...

Certificate Submission

Incorporation of Subsidiary

Meeting Intimation

Investor Meeting

Earnings Transcript Disclosure

Earnings Conference Call

Financial Results

Confirmation of Proceeds Ut...

Earnings Conference Call

Certificate Submission

Earnings Conference Call

Incorporation of Subsidiary...

Conference Call Recording U...

Investor Presentation

Clarification on Volume Inc...

Earnings Conference Call

Financial Results

Certificate under Reg. 74 (5)

Allotment approved

Incorporation of Wholly Own...

Approval for Parecoxib 40mg...

Meeting Schedule

Advertisement Publication

Analyst/Investor Meeting

AGM Announcement

Preferential Issue

Earnings Guidance

Financial Statements

Financial Statements

Equity Investments

Divestment of Assets

Earnings Transcript Uploaded

Analyst/Investor Meet Intim...

Financial Statements

Equity Investments

Geographic Expansion

Financial Statements

Management Changes

Debt Restructuring

External Links:

Data:

GUFIC BIOSCIENCES LTD. has been granted a Patent of Addition for a freeze-dried parenteral composition of omadacycline tosylate with improved stability.

AI Assistant

Gufic BioSciences Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.